meglumine has been researched along with Diabetes Insipidus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishii, Y; Koshimoto, Y; Maeda, M; Naiki, H; Nakakuki, K | 1 |
| Aricò, M; Beluffi, G; Campani, R; Genovese, E; Maghnie, M; Severi, F; Villa, A | 1 |
2 other study(ies) available for meglumine and Diabetes Insipidus
| Article | Year |
|---|---|
MR of pituitary metastasis in a patient with diabetes insipidus.
Topics: Aged; Carcinoma, Small Cell; Contrast Media; Diabetes Insipidus; Drug Combinations; Fatal Outcome; Gadolinium DTPA; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Pituitary Gland; Pituitary Neoplasms | 1995 |
Evolving pituitary hormone deficiency is associated with pituitary vasculopathy: dynamic MR study in children with hypopituitarism, diabetes insipidus, and Langerhans cell histiocytosis.
Topics: Adolescent; Child; Child, Preschool; Contrast Media; Diabetes Insipidus; Drug Combinations; Female; Gadolinium DTPA; Growth Hormone; Histiocytosis, Langerhans-Cell; Humans; Hypopituitarism; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Pituitary Gland; Pituitary Hormones; Thyrotropin | 1994 |